Publication | Closed Access
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
296
Citations
20
References
2012
Year
Phase 1/2Lymphoid NeoplasiaHematological MalignancyRefractory Mantle-cell LymphomaOncologyHematologyPathologyImmunotherapyMedicineRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1